The Histone Methyltransferase KMT2D is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration Resistant Prostate Cancer [MSKPCA3 Bulk RNA-Seq]
Single-cell RNA-seq · human · 12 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × MSKPCA3_control_DMSO vs 3 × MSKPCA3_shKMT2D_DMSO vs 3 × MSKPCA3_control_GDC0941 vs 3 × MSKPCA3_shKMT2D_GDC0941Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate CancerCancer research · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE296116_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1257821 and SRA study SRP582599. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8965441 MSKPCA3_control_DMSO_rep1 MSKPCA3_control_DMSO
- GSM8965442 MSKPCA3_control_DMSO_rep2 MSKPCA3_control_DMSO
- GSM8965443 MSKPCA3_control_DMSO_rep3 MSKPCA3_control_DMSO
- GSM8965444 MSKPCA3_shKMT2D_DMSO_rep1 MSKPCA3_shKMT2D_DMSO
- GSM8965445 MSKPCA3_shKMT2D_DMSO_rep2 MSKPCA3_shKMT2D_DMSO
- GSM8965446 MSKPCA3_shKMT2D_DMSO_rep3 MSKPCA3_shKMT2D_DMSO
- GSM8965447 MSKPCA3_control_GDC0941_rep1 MSKPCA3_control_GDC0941
- GSM8965448 MSKPCA3_control_GDC0941_rep2 MSKPCA3_control_GDC0941
- GSM8965449 MSKPCA3_control_GDC0941_rep3 MSKPCA3_control_GDC0941
- GSM8965450 MSKPCA3_shKMT2D_GDC0941_rep1 MSKPCA3_shKMT2D_GDC0941
- GSM8965451 MSKPCA3_shKMT2D_GDC0941_rep2 MSKPCA3_shKMT2D_GDC0941
- GSM8965452 MSKPCA3_shKMT2D_GDC0941_rep3 MSKPCA3_shKMT2D_GDC0941
- GSE296115 The Histone Methyltransferase KMT2D is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration Resistant Prostate Cancer [LNCaP Bulk RNA-Seq] 16 samples shares kmt2d, methyltransferase, therapeutic, plasticity, castration, resistant, critical
- GSE253957 Methylation of the epigenetic regulator KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer [SMYD2_KD_RNA] 12 samples shares kmt2d, therapeutic
- GSE293567 The H3K4 methyltransferase KMT2D is an essential cofactor for GATA1 at erythroid gene enhancers 67 samples shares kmt2d, methyltransferase
- GSE316474 Regulation of melanoma cellular plasticity by the Mediator complex drives therapeutic resistance 66 samples shares therapeutic, plasticity
- GSE315960 Epigenetic regulation of melanoma phenotypic plasticity and therapeutic resistance 27 samples shares therapeutic, plasticity
- GSE295834 Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target [RNA-Seq] 18 samples shares therapeutic, plasticity
- GSE316110 Epigenetic regulation of melanoma phenotypic plasticity and therapeutic resistance [ChIP-seq] 39 samples shares therapeutic, plasticity
- GSE282082 Circular RNA circTNK2 contributes to immune evasion and acts as a nanotherapeutic target in tamoxifen-resistant ER-positive breast cancer 10 samples shares therapeutic, resistant
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.